A malaria vaccine has been developed

A vaccine against malaria that mimics the effect of mosquito bites has shown promising results when 100% protection for volunteer participants - the researchers said.

The vaccine tested, called PfSPZ, was made by Maryland-based Sanaria, which contains live malaria parasites collected through a process of cutting the salivary glands of mosquitoes. meticulous

These immature parasites are then weakened so they cannot cause disease and are introduced into a vaccine. This vaccine will be injected into a person's blood vessels a number of times, once a month apart.

The new vaccine shows a positive effect when protecting people from malaria

All 6 volunteers were given 5 doses of these high-dose vaccines into the bloodstream to protect against the disease - according to results published in the American Journal of Science.

6 out of 9 volunteers in a group of clients receiving 4 doses of the vaccine at high doses are also resistant to malaria.

According to the World Health Organization, there is no vaccine for malaria - the disease affects about 220 million people in 2010 and causes 660,000 deaths. Most death victims are African children. The co-authors of this study are 2 Hoffman and Robert Seder scientists.

Scientists say this product can protect people from malaria for a period of 6 to 10 months. In addition, this species should be effective for all types of malaria parasites.

Some medical trials are expected to be conducted in Tanzania, Germany and the United States. According to Hoffman, it will take about four years before a vaccine can be marketed. He said about $ 110 million was invested in the vaccine.